Back
Syndax Pharmaceuticals Stock Predictions

Disrupting a Trillion-Dollar Industry
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
10
SNDX
Syndax Pharmaceuticals
Last Price:
$10.13
Seasonality Move:
2.34%
7 Day Trial
ALL ACCESS PASS
$
7

Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with NasdaqSyndax Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Syndax Pharmaceuticals has on average historically risen by 10.3% based on the past 9 years of stock performance.
-
Syndax Pharmaceuticals has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Syndax Pharmaceuticals Stock Undervalued?The current Syndax Pharmaceuticals [SNDX] share price is $9.93. The Score for SNDX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
-
SNDX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Syndax Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Syndax Pharmaceuticals has on average historically risen by 10.3% based on the past 9 years of stock performance.
Syndax Pharmaceuticals Stock Rating
Sell
10
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals overpriced?
-
Syndax Pharmaceuticals has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Syndax Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
syndax.com
52-Week Data
52-Week High:
25.07
52-Week Low:
8.58
Prediction Charts
Market Cap:
854.5M
Price in USD:
9.93
Volume:
2.8M
Beta:
1.25
Technical Analysis
SMA50:
11.87
SMA100:
13.04
SMA200:
15.59
52-Wk Change:
-51.04%
Stock Predictions
-
Is Syndax Pharmaceuticals stock public?Yes, Syndax Pharmaceuticals is a publicly traded company.
-
What is the Syndax Pharmaceuticals stock quote today?The Syndax Pharmaceuticals stock price is 9.93 USD today.
-
How to buy Syndax Pharmaceuticals stock online?You can buy Syndax Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-7 | 10.91 | 9.99 | 11.12 | 9.91 |
May-8 | 10.05 | 11.01 | 11.42 | 9.67 |
May-9 | 11.17 | 10.70 | 11.48 | 10.69 |
May-12 | 11.09 | 10.99 | 11.34 | 10.37 |
May-13 | 11.03 | 10.19 | 11.11 | 10.10 |
May-14 | 10.18 | 9.28 | 10.45 | 9.24 |
May-15 | 9.27 | 8.95 | 9.30 | 8.58 |
May-16 | 8.97 | 9.05 | 9.15 | 8.80 |
May-19 | 8.95 | 9.30 | 9.35 | 8.75 |
May-20 | 10.03 | 10.57 | 10.70 | 10.03 |
May-21 | 10.49 | 10.65 | 11.11 | 10.30 |
May-22 | 10.44 | 10.81 | 10.84 | 10.14 |
May-23 | 10.98 | 9.85 | 11.04 | 9.83 |
May-27 | 9.95 | 9.93 | 10.15 | 9.83 |
Syndax Pharmaceuticals Earnings
Syndax Pharmaceuticals Earnings Report: Per Share Syndax Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Syndax Pharmaceuticals Forecast Revenue Growth
Syndax Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Syndax Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.91 per share, and an increase next year of $1.14 per share.
* Syndax Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.